|
|
|
9th Global Drug Delivery & Formulation Summit |
 |
|
12-14 March 2018
Maritim proArte Hotel Berlin
The growth of biopharma, patient compliance issues and ever
increasing regulatory requirements have encouraged us to adopt a drug delivery
mind set from discovery through to production.
Every year we see innovation and breakthroughs at all levels
of drug and formulation development. From big pharma, through the smaller
biotechnology companies all the way to university research teams and spin outs.
The DDF Summit brings the most interesting studies and
exciting technologies to you. This year there will be 4 dedicated streams
focusing on Small Molecules, Biologics, Technology & Innovation and for the
first-time Device Development.
You’ll find new technologies, concepts and case studies in
areas such as… • Less traditional delivery routes including nasal, ocular & subcutaneous
• Targeted and controlled release technologies and nanoparticles
• Increasing stability of amorphous solid dispersion
• QbD in biopharmaceutical development
• Formulation strategies for multiple injection dosing
• Oral delivery of peptides
• Continuous manufacturing and processing for improved efficiency
• User friendly technologies for improving patient convenience and
compliance
• Regulatory strategies for combination products
• Drug stability and material selection in combination products
Visit www.ddfevent.comor contact maxconferences@markallengroup.comfor more information. |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
Outsourcing in Clinical Trials Europe
26-27 October 2020, Paris, France
Arena International are delighted to announce the return of Outsourcing
in Clinical Trials Europe. Part of our global series of events, this
flagship show will attract the leading clinical professionals from
across Europe. The 10th Annual event will be hosted in Paris.
More info >> |
|
 |
White Papers |
 |
|
BioT ULT Transporter
BioCision
The growth of biobanking, cell therapy, and complex biopharmaceutical therapies like cancer vaccines has created a strong need for products and processes to ensure the stability of temperature-sensitive biospecimens. Proper collection, handling, characterization, packaging and shipping of these materials is critical, as poor sample handling impacts researchers working on discovery with patient samples, as well as clinicians treating patients with cutting edge therapies.
This white paper describes in detail the BioCision BioT™ ULT Transporter, the first-of-its-kind dry ice-based portable cooling system that maintains a stable -75° to -50°C environment for over 24 hours on one charge of dry ice, enabling reliable handling and transfer of valuable temperature-sensitive biospecimens as part of a larger cold chain standardization process.
More info >> |
|
 |
News and Press Releases |
 |
Ypsomed and Dexcom enter into partnership to drive closed loop system
Burgdorf/San Diego – Ypsomed (SWX:YPSN) and DexCom Inc. (NASDAQ:DXCM), the world's leading provider of continuous glucose monitoring (CGM) systems, announce their partnership to drive development of a hybrid closed loop system. The partnership is an important milestone in the further development of individualised diabetes therapy. In a first step, CGM data from Dexcom will be integrated into the mylife™ App from Ypsomed.
More info >> |
|
|
